Agios Pharmaceuticals Exec Says AQVESME Will Be Introduced At ~$425,000 Per Patient Per Year

Agios Pharmaceuticals, Inc. +0.14%

Agios Pharmaceuticals, Inc.

AGIO

28.52

+0.14%

- Reuters Citing Conf Call

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via